M&A Wave Pushes Data Valuations Up: Lock $0.85 Shares

The Flash Report

12 Mar 2026 — 1 min read

Industry consolidation is accelerating. AI-enabled buyouts hit $55B in the first half of 2025 — already surpassing all of last year. In adtech and martech, deal flow is at a multi-year high as global giants race to control the “pipes” and decision layers that drive revenue.

RAD Intel already is scaling - and for investors, it's early.

The AI tech ensures a who’s-who roster of Fortune 1000 clients and agency partners are already using their award-winning AI platform across brands like Hasbro, MGM, and Skechers.— turn attention into measurable returns. Fast Company calls RAD Intel “a groundbreaking step for the Creator Economy.”

We’ve raised $50M+ from 10,000+ investors, grown valuation 4,900% in four years, and have a leadership team with 225+ M&A transactions. Backed by Adobe and insiders from Google, Meta, and Amazon, we’ve secured our Nasdaq ticker ($RADI) and are positioned for contined growth.

Shares are available now at $0.85/share in our Regulation A+ round.

*Disclaimer: This is a paid advertisement for RAD Intel made pursuant to Regulation A+ offering and involves risk, including the possible loss of principal. The valuation is set by the Company and there is currently no public market for the Company's Common Stock. Nasdaq ticker “RADI” has been reserved by RAD Intel and any potential listing is subject to future regulatory approval and market conditions. Please read the offering circular and related risks at invest.radintel.ai.

The Biggest Unsolved Problem in Medicine?

Today, over half a billion people battle osteoarthritis. Each year, they spend $240B trying to halt the destruction of joint cartilage. But no cure exists on the market. Not for lack of trying, either. Big Pharma’s spent billions failing. Thankfully, Cytonics may have cracked the code. They discovered the

What if David and Goliath teamed up instead?

That’s what’s currently playing out in the foodservice industry, where industry goliaths Sodexo, Aramark, and Compass Group all partnered with foodtech startup Automated Retail Technologies. Why did they choose ART? With more than 150,000 venues managed by that trio alone, staffing overnight operations is costly and complicated.

The Key to This $500B Market Is in Your Bloodstream

Every year, $240B is spent on treating the symptoms of osteoarthritis, a disease that leads to joint degradation and, eventually, immobility. With 500M people afflicted, its total addressable market is worth over $500B. But not a single therapy has been able to actually stop it. The answer, it turns out,

Superhuman' Pre-IPO Stock Trading Under $1

Have you heard about this sub $1 Pre-IPO company that is making people "Superhumans"? It's all thanks to their new product called Visor. And it's very similar to Jarvis from the movie Iron Man. Investors are calling this a 'massive breakthrough'. But

Read more

The Biggest Unsolved Problem in Medicine?

What if David and Goliath teamed up instead?

The Key to This $500B Market Is in Your Bloodstream

Superhuman' Pre-IPO Stock Trading Under $1